English
Specials
    Premium
    My Alerts
    MoneycontrolGo PRO @₹99
    Moneycontrol PRO
    Check Credit Score
    Check Credit Score
    HomeNewsBusiness

    AstraZeneca-Merck Lynparza wins European Union approval for pancreatic cancer

    The approval was based on results from a late-stage trial in which Lynparza nearly doubled the lifespan of patients without disease progression or death when compared with placebo.

    Reuters
    July 08, 2020 / 12:30 PM IST

    AstraZeneca Plc and Merck & Co Inc said on Wednesday their blockbuster cancer treatment Lynparza won approval in the European Union for treating patients with a form of pancreatic cancer.

    The approval was based on results from a late-stage trial in which Lynparza nearly doubled the lifespan of patients without disease progression or death when compared with placebo.

    Reuters
    Tags: #AstraZeneca Plc #Business #European Union #Health #Merck & Co
    first published: Jul 8, 2020 12:15 pm

    Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347